SANUWAVE Health, Inc.
NASDAQ:SNWVMedical - Devices
+$0.18 today
- Market cap
- $51.01M
- Beta
- 1.34
- P/E (TTM)
- 5.0
- EPS (TTM)
- $1.87
Volume 0.04M
Average 0.11M
SNWV Other Income / Expenses
Net non-operating gains and losses, such as investment results, currency effects, and one-off items.
SANUWAVE Health, Inc.NASDAQ: SNWV
Other Income / Expenses · Q1 FY2026 · quarter ended Mar 2026
Other income / expenses remains negative
Q1 FY2026 other income / expenses was -$315K, compared with -$6.66M a year earlier. Trailing-twelve-month other income / expenses was $13.3M.
Context
- Other income / expenses amounted to 15.8% of revenue in FY2025, down 96.9 pp from a year earlier.
- Other income / expenses increased in 1 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly other income / expenses holds near -$315K or moves back toward the trailing-twelve-month quarterly average of $3.33M.
Sources:Income StatementText generated from reported figures; not investment advice.
Other Income / Expenses history
USD · from the income statement
- Latest · FY2025
- 6.95M USD
- Year-over-year change
- +118.9%
| Period | Period end | Other Income / Expenses | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 6.95M | +118.9% |
| FY2024 | 2024-12-31 | (36.76M) | -45.5% |
| FY2023 | 2023-12-31 | (25.26M) | -1786.7% |
| FY2022 | 2022-12-31 | (1.34M) | +89.8% |
| FY2021 | 2021-12-31 | (13.09M) | — |
Other Income / Expenses vs competitors
How SNWV compares with its peers on the latest reported figures
- SNWV's LTM Mar 2026 other income / expenses of $13.3M is the 2nd highest of the 11 companies compared; the peer median is -$1.06M.
- Its year-over-year change of +133.3% is the highest of 11, against a peer median of -38.3%.
- Other income / expenses amounts to 30.0% of revenue for SNWV, versus a peer median of 8.7%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $13.42M | +0.9% | — | 9.3% | |
| LTM Mar 2026 | $13.3M | +133.3% | — | 30.0% | |
| LTM Mar 2026 | $5.44M | -67.9% | -1.8% | 19.3% | |
| LTM Mar 2026 | $5.36M | -8.8% | +51.2% | 1.5% | |
| LTM Mar 2026 | $4.79M | +95.0% | +39.6% | — | |
| LTM Mar 2026 | -$492K | +87.4% | — | 1.2% | |
| LTM Mar 2026 | -$1.62M | -403.6% | — | 2.0% | |
| LTM Mar 2026 | -$5.01M | -234.1% | — | 8.7% | |
| LTM Mar 2026 | -$7.09M | +65.4% | — | 6.0% | |
| LTM Dec 2025 | -$16.11M | -661.0% | — | 123.7% | |
| LTM Mar 2026 | -$117.99M | -8328.2% | — | 1230.5% | |
| Peer median (excluding SNWV) | -$1.06M | -38.3% | +39.6% | 8.7% | |
Competitors are the stored peer set for SNWV. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 13.01M | 16.74M | 20.4M | 32.63M | 44.05M |
| Cost of Revenue | 4.99M | 4.33M | 6.04M | 8.08M | 10.08M |
| Gross Profit | 8.02M | 12.41M | 14.36M | 24.55M | 33.97M |
| Gross Margin | 61.7% | 74.1% | 70.4% | 75.2% | 77.1% |
| Research & Development | 1.1M | 567K | 579K | 673K | 1.35M |
| Selling, General & Admin | 20.28M | 20.03M | 13.57M | 17.67M | 26.79M |
| Operating Expenses | 22.17M | 21.36M | 14.9M | 19.13M | 29.02M |
| Depreciation & Amortization | 1.24M | 952K | 1.03M | 1.15M | 1.28M |
| EBITDA | (18.9M) | 4.79M | (9.15M) | (16.56M) | 19.43M |
| EBITDA Margin | -145.3% | 28.6% | -44.9% | -50.8% | 44.1% |
| Operating Income | (14.14M) | (8.95M) | (540K) | 5.42M | 4.95M |
| Operating Margin | -108.7% | -53.5% | -2.6% | 16.6% | 11.2% |
| Interest Income | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 7.1M | 14.13M | 15.62M | 13.64M | 6.25M |
| Other Income / Expenses | (13.09M) | (1.34M) | (25.26M) | (36.76M) | 6.95M |
| Income Before Tax | (27.23M) | (10.29M) | (25.8M) | (31.35M) | 11.9M |
| Pre-Tax Margin | -209.3% | -61.5% | -126.5% | -96.1% | 27.0% |
| Income Tax Expense | 28K | 2K | 4K | 27K | 86K |
| Net Income | (27.26M) | (10.29M) | (25.81M) | (31.37M) | 11.81M |
| Net Margin | -209.5% | -61.5% | -126.5% | -96.1% | 26.8% |
| EPS (Basic) | (19.72) | (7.02) | (12.19) | (7.03) | 1.38 |
| EPS (Diluted) | (19.72) | (7.02) | (12.19) | (7.03) | 0.41 |
| Weighted Avg Shares | 1.38M | 1.47M | 2.12M | 4.46M | 8.56M |
| Weighted Avg Shares (Diluted) | 1.38M | 1.47M | 2.12M | 4.46M | 9.08M |
SANUWAVE Health, Inc.
NASDAQ:SNWV
Intrinsic Alpha fair value
Locked
Current Price
$5.93
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.